Stocks · Health care · Pharmaceutical Preparations

Immunome Inc.

IMNM Clue Score30

United States Fiscal year ends December CIK 0001472012 Results filed 11 Aug 2026

Add to watchlist

What the insiders did Net buying

By person

19 insiders · 75 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Isaac Barchas

Director

—

$18.27M (12) scheduled

−$18.27M

92,211

0.0812%

$2.33M

−89.7%

Clay B Siegall

President and CEO

$7.26M (11)

—

+$7.26M

870,704

0.7666%

$22.05M

+478.8%

Michael Rapp

Director

$3.33M (8)

—

+$3.33M

1,416,744

1.25%

$35.87M

+271.7%

Max Rosett

Chief Financial Officer

—

$2.75M (4) scheduled

−$2.75M

101,287

0.0892%

$2.56M

+410.1%

Kinney Horn

Chief Business Officer

—

$2.30M (2) scheduled

−$2.30M

0

0.0000%

$0.00

—

Robert Lechleider

Chief Medical Officer

$149.80K (1)

$2.34M (5) scheduled

−$2.19M

69,805

0.0615%

$1.77M

—

Philip Wagenheim

Director

$247.73K (1)

$1.34M (2)

−$1.09M

341,147

0.3004%

$8.64M

−11.1%

Jack Higgins

Chief Scientific Officer

—

$587.53K (3) scheduled

−$587.53K

60,250

0.0530%

$1.53M

+5,925%

Philip Tsai

Chief Technical Officer

$506.50K (3)

—

+$506.50K

81,550

0.0718%

$2.06M

—

Jean Jacques Bienaime

Director

$641.23K (11)

$203.82K (2)

+$437.41K

43,415

0.0382%

$1.10M

+470.1%

Bruce Turner

Chief Strategy Officer

$249.99K (1)

—

+$249.99K

42,300

0.0372%

$1.07M

—

Purnanand D Sarma

President and CEO

$193.31K (1)

—

+$193.31K

10,500

0.0092%

$265.86K

—

John L Lamattina

Director

$101.03K (2)

—

+$101.03K

66,953

0.0589%

$1.70M

—

Michael Lefenfeld

Director

$86.15K (3)

—

+$86.15K

40,747

0.0359%

$1.03M

—

I Wistar Morris III

10% owner

—

—

—

920,939

0.8108%

$23.32M

—

Franklyn G Prendergast

Director

—

—

—

60,840

0.0536%

$1.54M

—

Michael Widlitz

Director

—

—

—

51,315

0.0452%

$1.30M

—

Sandra G. Stoneman

Chief Legal Officer & GC

—

—

—

43,805

0.0386%

$1.11M

+688.6%

Richard A Baron

Director

—

—

—

2,343

0.0021%

$59.32K

—